Deterioration Index Version 2
Epic Systems Corporation · Decision date Sep 18, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 18, 2026 for Deterioration Index Version 2, submitted by Epic Systems Corporation under 510(k) number K260008. The device is clinical decision support software that calculates a deterioration risk score for adults aged 18 and older in inpatient, observation, or emergency department observation settings, and it must be used with the Epic electronic health record. It is regulated as an adjunctive predictive cardiovascular indicator under 21 CFR 870.2210, Class II, product code QNL.
The submission cites eCARTv5 Clinical Deterioration Suite (K233253) as predicate. The summary describes differences including a broader composite outcome, a 72-hour rather than 24-hour mortality horizon, scheduled rather than documentation-triggered scoring, and additional inputs. A retrospective validation across three U.S. sites is reported, but the available excerpts do not give complete performance figures or the full intended-use statement, so those details remain unverified here. SESE denotes clearance, not PMA approval.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260008
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Epic Systems Corporation
- Product code
- QNL
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Medium-Term Adjunctive Predictive Cardiovascular Indicator.
- Applicant
- Epic Systems Corporation
- Product code
- QNL
- FDA device class
- 2
FDA decision timeline
K260008 received
Application receipt date recorded by FDA.
K260008 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Epic Systems Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Verona, WI
Sources and methodology
- Original FDA record: K260008
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records